Effects of SGLT2 inhibitors on cardiovascular outcomes

Medicine and Dentistry

• Cardiovascular System 100%
• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Blood Pressure 50%
• Clinical Trial 50%
• Sodium Glucose Cotransporter 2 50%
• Body Weight 50%
• Feeding 50%
• Drug Administration 50%

Nursing and Health Professions

• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Glucose Blood Level 50%
• Food and Drug Administration 50%
• Clinical Evaluation 50%
• Body Weight 50%
• Blood Pressure 50%
• Sodium Glucose Cotransporter 2 50%
• Sodium Glucose Cotransporter 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Clinical Trial 50%
• Drug Administration 50%
• Sodium Glucose Cotransporter 2 50%
• Sodium Glucose Cotransporter 50%